Interclean Shanghai

Max Healthcare to Invest $450 Million in India’s Health System

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media PackNow

– Book a Conference Call

Leave Message for Us to Get Back

Related stories

EU Begins Revision of Medical Device...

The European Commission has gone on to initiate a...

FDA Seeks Opinion on AI-Enabled Medical...

The U.S. Food and Drug Administration (US FDA) is...

FDA Approves Zenix Monitor-Defibrillator from ZOLL

ZOLL®, which happens to be an Asahi Kasei company...

MHRA in the UK Accelerates AI...

The Medicines and Healthcare Products Regulatory Agency (MHRA) from...

Max Healthcare plans to invest $450 million in the next four years to add capacity to India’s health care system as the Covid-19 pandemic hit it. “We want to double our capacity in cities like Mumbai and New Delhi,” Abhay Soi, Chairman and Managing Director of Max Healthcare.

The investment will boost capacity at existing hospitals and increase the firm’s landholdings. Max Healthcare will continue focusing on medical tourism. The expansion plans came after the pandemic as a country with around 1.4 billion people who suffered due to the healthcare system. The corona wave in April and May flooded hospitals and left many Indian citizens pleading for medical resources.

Indian hospitals and the government said that the pandemic has led to improvements in the health care system, with many facilities like oxygen plants switching rapidly between Covid medical care and non-Covid treatments during the next Covid-19 wave.

Latest stories

Related stories

EU Begins Revision of Medical Device Regulatory Framework

The European Commission has gone on to initiate a...

FDA Seeks Opinion on AI-Enabled Medical Devices Regulation

The U.S. Food and Drug Administration (US FDA) is...

FDA Approves Zenix Monitor-Defibrillator from ZOLL

ZOLL®, which happens to be an Asahi Kasei company...

MHRA in the UK Accelerates AI Rollout in the NHS

The Medicines and Healthcare Products Regulatory Agency (MHRA) from...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Translate »